Latest Headlines

  1. Novotech Publishes Comprehensive Report On The Global Vaccine Clinical Trials Landscape 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders.

  2. Novotech Releases Report On Global Bladder Cancer Clinical Trials, Offering Insights For Oncology Advancement 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors. 

  3. Novotech Releases Comprehensive Report On The Global Clinical Trial Landscape For Small Cell Lung Cancer (SCLC) 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024, providing an in-depth analysis of current trends, challenges, and opportunities in SCLC clinical trials worldwide.

  4. The Future Of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights From Global Research 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, shares new insights into the global clinical trial landscape for Diffuse Large B-Cell Lymphoma (DLBCL), further reinforcing its leadership in oncology research.

  5. Global Cell And Gene Therapy Trials: Driving Innovation In Oncology And Beyond 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly evolving field of cell and gene therapies. The report provides critical insights into the growth of clinical trials, innovations and strategic opportunities, shaping the future of this field.

  6. Novotech Releases In-Depth Report On Cervical Cancer: Addressing A Global Health Challenge 12/4/2024

    Boston, USA – Novotech, the global full-service clinical Contract Research Organization (CRO), has released a new report, Cervical Cancer - Global Clinical Trial Landscape. This report offers a comprehensive analysis of the global cervical cancer research landscape, highlighting the crucial role of clinical trials in advancing treatment options. It outlines key geographic trends, emerging therapies, and future projections, providing valuable insights for researchers and healthcare professionals working to combat this disease.

  7. Novotech And Biostar Establish Strategic Partnership Following Biostar's HKEX Listing 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has announced a long-term strategic partnership with Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) (“Biostar”). This collaboration strengthens the commitment of both companies to advance clinical research, leveraging Novotech’s expertise and technical platforms to support Biostar’s clinical development plans. 

  8. Show Chwan Health Care System Joins Hands With Novotech To Accelerate The Quality Of International Clinical Trials Of New Drugs 12/4/2024

    Show Chwan Health Care System announced that it has signed a Memorandum of Understanding (MOU) with Novotech, a clinical research organization (CRO) in the Asia-Pacific region. It will use Novotech’s experience in planning clinical trials to target Changhua and the introduction of new clinical trial cases in Tainan, which will help doctors and patients get in touch with the latest treatment technologies and shorten the development period of new drugs.

  9. Cellistic Announces Successful Certification Of Its GMP Facility Dedicated To iPSC-Based Cell Therapies 11/21/2024

    Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and GMP certification of its first-of-its kind facility dedicated to manufacturing therapies based on induced pluripotent stem cells (iPSCs)

  10. Leading The Way: OpenClinica EDC Earns Major Recognition 11/18/2024